Related Experiment Video

Updated: Aug 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[Cardiovascular risk factors in the elderly]

G Ungureanu1, I D Alexa

  • 1Facultatea de Medicină Clinica Medicală IV, Universitatea de Medicină şi Farmacie Gr. T. Popa Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|July 2, 2002
PubMed

Insights

Cardiovascular risk factors differ in elderly patients, with some adult factors like hypertension persisting. Specific elderly risks include high iron, tachycardia, and altered cholesterol levels.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Context:

  • Cardiovascular risk assessment in adults differs significantly from that in the elderly population.
  • Traditional adult cardiovascular risk factors may present differently or be less prevalent in older adults.
  • Understanding age-specific risk factors is crucial for effective cardiovascular disease prevention in the elderly.

Purpose:

  • To review and synthesize recent findings on cardiovascular risk factors specifically in the elderly population.
  • To highlight the evolving nature of cardiovascular risk factors from adulthood to old age.
  • To identify both persistent and unique cardiovascular risks relevant to geriatric patients.

Summary:

  • While hypertension, smoking, hypercholesterolemia, diabetes mellitus, and obesity remain relevant, their prevalence and impact may change in the elderly.
  • High cholesterol and smoking status are often found at lower levels in the elderly compared to adults.
  • Specific risk factors in the elderly include elevated iron levels, sinus tachycardia, high homocysteine, low high-density lipoprotein-cholesterol (HDL-C), elevated lipoprotein-A, and certain coagulation factors.

Impact:

  • Informs clinical practice for geriatric cardiovascular risk assessment and management.
  • Contributes to targeted public health strategies for cardiovascular disease prevention in aging populations.
  • Provides a foundation for future research into the unique pathophysiology of cardiovascular disease in the elderly.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...